After a strong June 2025 session with senior leaders from across global biopharma, we are hosting our next invite-only Executive Education Workshop designed for C-level executives and investors shaping cross-border growth.
Co-Hosts: Jones Day and MSQ Ventures
Supporting Organizations: BioCentury Inc., American Healthcare Executive Association, KKH Advisors and The BayHelix Group
Date and time: Sunday, January 11, 2026, 9:00 AM to 12:30 PM
Location: San Francisco, Jones Day Office
Workshop Program:
9:30 – 10:10 AM: Navigating Global Growth and M&A: Insights from the Mirum–Bluejay Journey with Dr. Keting Chu, Founder & CEO, Bluejay Therapeutics
10:10 – 10:50 AM: NewCo Structure that work in China Biotech Company – with Robert Latta & David Lee, Partners, Jones Day
10:50 AM – 11:30 AM: Strategic Considerations for U.S. Markets: Navigating today’s FDA with strategic precision and developing drug pricing strategies to protect innovative investments with Melissa Mannion & Steve Forster, Partners, Jones Day
11:30AM -12:10PM: Fireside Chat with Les Funtleyder Fund Manager and Interim CEO, CFO, Member, Board of Directors, Applied Therapeutics & Kimberly Ha, Founder & CEO of KKH Advisors
12:10 – 12:30 PM: Closing Remarks
12:30 – 1:00 PM: Networking Lunch & Open Discussion
Session Speakers
This workshop centers on practical learning and real discussion. Through immersive case studies and expert-led conversations, participants will explore current priorities and approaches for global biopharma expansion, partnership strategy, and cross-border collaboration.
Sessions will be led by experienced dealmakers from pharma, biotech, investment, and regulatory backgrounds, including a former FDA official.
Attendance is limited to keep the room focused and interactive.